Impact of Acute ITTP Therapies on Long Term Neurologic and Cognitive Outcomes in ITTP Survivors

NCT06358703 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombotic Thrombocytopenia

Interventions

DRUG: Caplacizumab

Sponsor

US Thrombotic Microangiopathy Alliance